Lexicon Pharma (LXRX) Posts Q3 Loss of 6c/Share

November 12, 2013 6:49 AM

Lexicon Pharmaceuticals (Nasdaq: LXRX) reported Q3 EPS of ($0.06), $0.05 worse than the analyst estimate of ($0.01). Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found